Journal
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Volume 122, Issue -, Pages 37-43Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcdb.2021.07.010
Keywords
ICM; Reprogramming; Fibroblast; Myocardial infarction
Categories
Funding
- NIH/NHLBI R01 grants [HL139976, HL139880]
- American Heart Association [20EIA35320128]
- AHA [18TPA34180058, 20EIA35310348]
- NIH/NHLBI [R35HL155656]
Ask authors/readers for more resources
The adult human heart has limited regenerative capacity. Direct cardiac reprogramming, which converts cardiac fibroblast into functional cardiomyocyte-like cells, holds great promise for heart regeneration. Significant progress has been made in improving reprogramming efficiency and understanding the underlying molecular mechanisms.
The adult human heart has limited regenerative capacity. As such, the massive cardiomyocyte loss due to myocardial infarction leads to scar formation and adverse cardiac remodeling, which ultimately results in chronic heart failure. Direct cardiac reprogramming that converts cardiac fibroblast into functional cardiomyocyte-like cells (also called iCMs) holds great promise for heart regeneration. Cardiac reprogramming has been achieved both in vitro and in vivo by using a variety of cocktails that comprise transcription factors, microRNAs, or small molecules. During the past several years, great progress has been made in improving reprogramming efficiency and understanding the underlying molecular mechanisms. Here, we summarize the direct cardiac reprogramming methods, review the current advances in understanding the molecular mechanisms of cardiac reprogramming, and highlight the novel insights gained from single-cell omics studies. Finally, we discuss the remaining challenges and future directions for the field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available